Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Cash from Operations (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Cash from Operations for 2 consecutive years, with 18343000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 1.59% to 18343000.0 in Q4 2025 year-over-year; TTM through Oct 2025 was 86670000.0, a N/A change, with the full-year FY2025 number at 77608000.0, down 7.44% from a year prior.
  • Cash from Operations was 18343000.0 for Q4 2025 at Kestra Medical Technologies, up from 26274000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 14948000.0 in Q2 2024 to a low of 26274000.0 in Q3 2025.